Reversing epithelial to mesenchymal transition by targeted epigenetic editing in breast cancer

Status	Finished
Effective start/end date	1/01/18 → 31/12/22

Access Project

Synthetic Epigenetic Reprogramming of Mesenchymal to Epithelial States Using the CRISPR/dCas9 Platform in Triple Negative Breast Cancer
Waryah, C., Cursons, J., Foroutan, M., Pflueger, C., Wang, E., Molania, R., Sorolla, A., Wallis, C., Moses, C., Glas, I., Magalhães, L., Thompson, E. W., Fearnley, L. G., Chaffer, C. L., Davis, M., Papenfuss, A. T., Redfern, A., Lister, R., Esteller, M. & Blancafort, P., 4 Aug 2023, In: Advanced Science. 10, 22, 2301802.
Research output: Contribution to journal › Article › peer-review

Open Access
5 Citations (Scopus)
Unpacking the Complexity of Epithelial Plasticity: From Master Regulator Transcription Factors to Non-Coding RNAs
Waryah, C., Alves, E., Mazzieri, R., Dolcetti, R., Thompson, E. W., Redfern, A. & Blancafort, P., Jun 2023, In: Cancers. 15, 12, 3152.
Research output: Contribution to journal › Review article › peer-review

Open Access
Epigenome engineering: new technologies for precision medicine
Sgro, A. & Blancafort, P., 16 Dec 2020, In: Nucleic Acids Research. 48, 22, p. 12453-12482 30 p.
Research output: Contribution to journal › Article › peer-review

Open Access
27 Citations (Scopus)